BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 570768)

  • 1. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)].
    Schmid P; Pavek P; Klein W
    Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L; Hess OM; Grimm J; Krayenbühl HP
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of the systolic anterior motion of the mitral valve and site of the intraventricular pressure gradient in hypertrophic obstructive cardiomyopathy (author's transl)].
    Nagata S; Sakakibara H; Beppu S; Park YD; Masuda Y; Nimura Y
    J Cardiogr; 1981 Dec; 11(4):1077-87. PubMed ID: 7201490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Short and long term hemodynamic effects of amiodarone in patients with hypertrophic obstructive myocardiopathy. Combined evaluation using invasive and noninvasive methods].
    Huerta D; Vidal J; Cárdenas M
    Arch Inst Cardiol Mex; 1992; 62(1):45-53. PubMed ID: 1562208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of verapamil on diastolic left ventricular function in myocardial hypertrophy of different origin.
    Hess OM; Murakami T; Krayenbühl HP
    Z Kardiol; 1987; 76 Suppl 3():82-6. PubMed ID: 2963452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
    Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
    J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Echocardiographic diagnosis of obstructive myocardiopathies: study of the systolic anterior motion of the mitral valve and septal hypertrophy as compared with the hemodynamic and mechanographic findings. Evolution under medical treatment].
    Drobinski G; Eugène M; Vachon JM; Béjean-Lebuisson A; Evans JI; Kin G; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1979 Apr; 72(4):332-40. PubMed ID: 38761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anterolateral papillary muscle motion before and after septal myotomy in hypertrophic obstructive cardiomyopathy].
    Nagata S; Park YD; Ohmori F; Beppu S; Kawazoe K; Fujita T; Sakakibara H; Nimura Y
    J Cardiol; 1988 Jun; 18(2):363-72. PubMed ID: 3249263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
    Lemke R; Hopf R; Kober G; Kaltenbach M
    Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
    [No Abstract]   [Full Text] [Related]  

  • 12. Echocardiographic assessment of left ventricular wall motion in hypertrophic cardiomyopathy.
    Gullace G; Knippel M; Ravizza P; Savoia MT
    G Ital Cardiol; 1982; 12(8):581-9. PubMed ID: 6892016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of hypertrophic obstructive cardiomyopathy refractory to medical treatment and selection of surgical methods.
    Hirasawa Y; Kawai A; Niinami H; Aomi S; Nishida H; Endo M; Koyanagi H; Tanimoto K; Ishizuka N
    J Card Surg; 2005; 20(1):8-15. PubMed ID: 15673404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic apical cardiomyopathy: a subtype of hypertrophic cardiomyopathy.
    Abinader EG; Rauchfleisch S; Naschitz J
    Isr J Med Sci; 1982 Oct; 18(10):1005-9. PubMed ID: 6890950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitral systolic anterior motion and left ventricular function in obstructive cardiomyopathy].
    Béjean-Lebuisson A; Drobinski G; Komajda M; Chollet D; Evans JI; Eugène M; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1375-83. PubMed ID: 6422873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient systolic anterior movement of the mitral valve (SAM) without asymmetric septal hypertrophy (case report with post-mortem examination) (author's transl)].
    Daniel W; Freudenberg H; Walpurger G; Lichtlen P
    Z Kardiol; 1979 Feb; 68(2):93-7. PubMed ID: 154783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conservative medical treatment of hypertrophic myocardiopathies].
    Kaltenbach M; Hopf R
    Z Kardiol; 1982 Dec; 71(12):795-805. PubMed ID: 6891871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)].
    Kuhn H; Thelen U; Leuner C; Köhler E; Bluschke V
    Z Kardiol; 1980 Oct; 69(10):669-75. PubMed ID: 7192910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.